Technology

Gladia Launches Solaria, the First Fully Multilingual, Next-Generation Speech-to-Text Model for Global Scalability

Published

1 year ago

April 2, 2025

Solaria delivers unmatched accuracy, speed, and native-level transcription in 100 languages—including 42 underserved by any other STT model.

PARIS, April 2, 2025 /PRNewswire/ — Gladia, an AI transcription and audio intelligence provider, today announced the launch of Solaria, a next-gen automatic speech recognition (ASR) model designed to redefine real-time communications for call centers and other voice-first platforms.

While outsourcing has long been a cost reduction strategy in the call center industry, businesses now face a new, critical challenge: providing seamless, multilingual support at scale. With 49% of global executives reporting financial losses due to language barriers1, the demand for scalable, high-quality multilingual solutions has never been greater. Solaria now empowers businesses to enhance and expand their customer service operations with AI-powered voice technology that delivers unmatched language coverage—supporting 40+ languages previously inaccessible with other solutions—without compromising quality or speed.

Solaria: An Enterprise-Ready Model for Global Customer Experience

The only speech-to-text (STT) engine built for true global scalability, Solaria was designed to meet the demands of today’s contact centers, where both AI automation and human agents need high-accuracy, low-latency, and real-time multilingual support to succeed.

The model achieves industry-leading results in speech recognition, delivering both unmatched accuracy and ultra-fast processing speed. Recent benchmarks show Solaria has reached an unmatched 94% Word Accuracy Rate (WAR) average in English, Spanish, French and other common languages, while maintaining an ultra-low latency of 270 ms, making the conversation feel natural and responsive.

While real-time STT is often measured by speed alone, accuracy and language coverage are equally crucial for businesses providing seamless services across regions.

Unlike other STT models that prioritize speed over usability, Solaria balances industry-leading accuracy and speed with unmatched language coverage—100 languages in total, with exclusive support for 42 languages not matched by competitors. For high-population markets and key outsourcing hubs like Bangladesh, India, and The Philippines, native-level accuracy in regional languages is now offered through Solaria.

With native-level transcription, real-time code-switching, and translation across all supported languages, businesses can expand into global markets without constraints.

Designed for enterprise-scale voice automation, Solaria delivers:

Best-in-class accuracy in high-population languages such as Tagalog, Bengali, Punjabi, Tamil, Urdu, Persian, and Marathi.Ability to adapt the model to industry-specific terminology (like medical or financial jargon) and have it extract critical data, like names, addresses, and numericals.Adaptive speech processing, ensuring high accuracy in noisy call center environments.Enterprise-grade data security, in full compliance with GDRP, HIPPA, and SOC 2.

With the addition of Solaria to its product portfolio, Gladia allows businesses to enhance customer service by improving AI-powered voice agents, making IVRs and virtual assistants more reliable across multiple languages, while also optimizing human-assisted workflows with real-time transcriptions and translations to help agents provide more effective assistance.

“Speech is the most natural way to connect with the world—for the first time, automated speech recognition is closing the divide, enabling humans and AI to truly speak the same language,” said Jean-Louis Quéguiner, Chief Executive Officer and Co-Founder, Gladia. “With Solaria, we have made a breakthrough in AI-powered voice technology that unlocks new opportunities for businesses, driving efficiency and delivering more seamless, impactful customer experiences across diverse languages and markets. Solaria is built for next-generation voice platforms ready to lead this transformation on a global scale.”

Serving more than 700 enterprise customers worldwide, including Attention, Circleback, Method Financial, and VEED.IO, Gladia delivers enterprise-grade service and scalability, backed by dedicated support and infrastructure in the U.S. and Europe, guaranteeing reliable performance for mission-critical applications. Companies looking to scale globally, optimize operational costs, and enhance customer experiences can start building with Gladia’s API today.

As part of the Solaria launch, Gladia has partnered with LiveKit, a leading open-source developer framework for real-time AI voice agents, to power real-time, multilingual translation within AI-driven applications. This gives developers global language capabilities out of the box through seamless integration with Gladia’s API.

Following its $16M Series A round in 2024 and today’s rollout of Solaria, Gladia has taken another critical step toward establishing itself as a leading end-to-end API audio infrastructure provider—combining speech recognition, generative AI, and voice generation capabilities to help enterprise users and developers tap into the full potential of real-time audio data.

About Gladia

Founded in 2022 by Jean-Louis Queguiner (ex-OVHCloud) and Jonathan Soto (ex-MIT/Sigfox), Gladia provides best-in-class speech AI tools that empower businesses to deliver faster, more accurate, and innovative communication solutions globally. Gladia’s product is adopted by over 150,000 users and 700 enterprise clients—including industry leaders like Attention, Circleback, Method Financial, and VEED.IO.

With offices in the U.S. and Europe, Gladia provides enterprise-grade support and infrastructure and offers flexible GPU hosting that can be deployed in the U.S., Europe, or globally, ensuring full compliance with local regulations.

More information can be found at Gladia’s website, or on Twitter or LinkedIn.

Media Contacts:
Anna Jelezovskaia
+33.766.868.657
ajelezovskaia@gladia.io

1 Slator. (2023) Slator 2023 Language Industry Market Report.
https://slator.com/2023-language-industry-market-report/

View original content to download multimedia:https://www.prnewswire.com/news-releases/gladia-launches-solaria-the-first-fully-multilingual-next-generation-speech-to-text-model-for-global-scalability-302417497.html

SOURCE Gladia

Technology

Baidu to Report First Quarter 2026 Financial Results on May 18, 2026

Published

30 minutes ago

April 23, 2026

BEIJING, April 23, 2026 /PRNewswire/ — Baidu, Inc. (Nasdaq: BIDU; HKEX: 9888 (HKD Counter) and 89888 (RMB Counter)) (“Baidu” or the “Company”), a leading AI company with strong Internet foundation, today announced that it will report its financial results for the First Quarter 2026 ended March 31, 2026, before the U.S. market opens on May 18, 2026. Baidu’s management will hold an earnings conference call at 8:00 AM on May 18, 2026, U.S. Eastern Time (8:00 PM on May 18, 2026, Beijing Time).

Please register in advance of the conference call using the link provided below. It will automatically direct you to the registration page of “Baidu Inc. Q1 2026 Earnings Conference Call”. Please follow the steps to enter your registration details, then click “Register”. Upon registering, you will then be provided with the dial-in number, the passcode, and your unique access PIN. This information will also be emailed to you as a calendar invite.

For pre-registration, please click:
https://s1.c-conf.com/diamondpass/10054331-iu876y.html

In the 10 minutes prior to the call start time, you may use the conference access information (including dial-in number(s), the passcode and unique access PIN) provided in the calendar invite that you have received following your pre-registration.

Additionally, a live and archived webcast of this conference call will be available at https://ir.baidu.com.

A replay of the conference call may be accessed by phone at the following number until May 25, 2026:
US: 1 855 883 1031
Reply PIN: 10054331

About Baidu

Founded in 2000, Baidu’s mission is to make the complicated world simpler through technology. Baidu is a leading AI company with strong Internet foundation, trading on Nasdaq under “BIDU” and the HKEX under “9888.” One Baidu ADS represents eight Class A ordinary shares.

View original content:https://www.prnewswire.com/news-releases/baidu-to-report-first-quarter-2026-financial-results-on-may-18-2026-302751204.html

SOURCE Baidu, Inc.

Technology

Phase 1 of 139th Canton Fair Introduces New Dedicated Product Zones as Emerging Technologies Take Center Stage

Published

30 minutes ago

April 23, 2026

GUANGZHOU, China, April 23, 2026 /PRNewswire/ — The 139th China Import and Export Fair (Canton Fair) has further optimized its exhibition landscape with nine new dedicated product zones, reflecting ongoing structural shifts in global trade and the continued upgrading of China’s export portfolio.

Among the most closely watched additions in Phase 1 are the consumer and agricultural drone zones, both making their debut at the Canton Fair and offering a focused showcase of applications in the low‑altitude economy. The consumer drone zone showcases progress in flight control, AI‑based obstacle avoidance and energy efficiency across imaging, tourism, emergency response and patrol. The agricultural drone zone highlights precision farming, with spraying, seeding and field‑management demonstrations showing terrain‑following, intelligent route planning, and precise payload control.

On day one, a Shandong‑based drone manufacturer welcomed buyers from 30+ countries, with over 50 strong leads. One buyer, after seeing load and wind‑resistance demonstrations, immediately confirmed three sample units and even proposed becoming a regional distributor.

Display technology is another focal point of Phase 1, highlighting advances in color accuracy, energy efficiency, and overall visual performance. Developments in fine‑grained control, expanded color gamut, and reduced power consumption point to a clear trend toward immersive viewing experiences combined with sustainability gains.

The smart wearables zone underscores how intelligent devices are becoming key interfaces for human‑machine interaction. From real‑time language translation and adaptive noise cancellation to long‑term health monitoring and AI‑enabled eyewear, wearables are evolving from standalone products into integrated systems that support communication, well‑being, and productivity across daily and professional settings.

The service robots zone further illustrates how artificial intelligence is moving from conceptual exploration to large‑scale deployment. Advanced robots showcased across industrial, commercial, medical, and public‑service scenarios demonstrate growing autonomy, multi‑sensory perception, and closer human-robot collaboration.

By bringing emerging technologies into clearer focus through dedicated zones, the 139th Canton Fair is reinforcing its function as a platform where trade trends take shape, innovation meets application, and global buyers gain early insights into cutting-edge technologies.

For pre-registration, please click: https://buyer.cantonfair.org.cn/register/buyer/email?source_type=16

Photo – https://mma.prnewswire.com/media/2963958/1.jpg

View original content:https://www.prnewswire.co.uk/news-releases/phase-1-of-139th-canton-fair-introduces-new-dedicated-product-zones-as-emerging-technologies-take-center-stage-302751520.html

Technology

OZMOSI Announces Strategic Partnership with Planview to Advance AI-Driven Planning in Pharmaceutical R&D

Published

30 minutes ago

April 23, 2026

By combining structured clinical intelligence with AI-driven portfolio planning, the partnership gives pharmaceutical teams a faster, clearer way to make high-stakes R&D decisions

SPRING LAKE HEIGHTS, N.J., April 23, 2026 /PRNewswire/ — OZMOSI, a leading provider of structured pharmaceutical development intelligence, today announced a strategic partnership with Planview, the leading AI-powered end-to-end platform for Strategic Portfolio Management (SPM) and Digital Product Delivery (DPD).

By integrating OZMOSI’s machine-readable clinical datasets directly into Planview’s AI-driven portfolio planning platform, external scientific data is now connected to internal R&D planning in one system, helping pharmaceutical organizations better predict market shifts, prioritize R&D investments, and make faster, more confident decisions.

This integration brings external clinical reality into internal R&D decision-making, so teams can plan based on what’s actually happening, not just on what they hope will happen.

The two organizations combine deep expertise in complementary areas, united by a shared focus on improving the quality and usability of data for strategic decision-making. OZMOSI provides structured, machine-readable intelligence across clinical trials, drug development programs, regulatory activity, and scientific literature, built on a consistent taxonomy that standardizes how data is connected and understood. Planview’s platform enables organizations to model complex investment scenarios, align initiatives with corporate strategy, and optimize resource allocation.

Together, these capabilities give teams a clearer, more complete view of the R&D landscape, grounded in clean, standardized data and strengthened by AI-driven analysis.

“AI is only as powerful as the data that fuels it,” said Beau Bush, President and Founder of OZMOSI. “Pharmaceutical organizations have no shortage of data, but too often it’s fragmented, inconsistent, and difficult to operationalize. By bringing OZMOSI’s structured data foundation together with Planview’s AI-driven planning capabilities, we’re enabling teams to move beyond disconnected analysis and toward truly integrated, forward-looking decision-making.”

“Strategic planning in pharmaceutical R&D is becoming increasingly dependent on advanced analytics and AI,” said Louise Allen, Chief Product Officer at Planview. “Integrating OZMOSI’s clinical intelligence into Planview’s platform enables pharmaceutical leaders to make better decisions by combining trusted external data with AI-driven planning

OZMOSI’s dataset spans more than 800,000 clinical trials, over 35,000 drugs, and 4,000 diseases and conditions. It brings together insights from clinical trial registries, regulatory filings, scientific literature, company disclosures, and industry announcements into a unified, structured dataset.

When integrated into Planview’s platform, this intelligence enables pharmaceutical and biotech organizations to evaluate competitive landscapes, identify emerging clinical trends, and simulate portfolio outcomes with unprecedented precision.

Together, OZMOSI and Planview are redefining how pharmaceutical organizations approach R&D strategy, ensuring that investment decisions are guided by accurate, standardized, and AI-ready data. By combining internal portfolio visibility with a continuously updated external view of the market, the partnership helps leaders not only understand what they have, but what to do next.

About OZMOSI

Founded in 2013, OZMOSI specializes in transforming complex pharmaceutical R&D intelligence into structured, machine-readable data. The company provides the foundation needed for accurate competitive analysis, product forecasting, and portfolio strategy. Through its proprietary taxonomy and semantic layer, OZMOSI connects fragmented data across the pharmaceutical ecosystem, enabling faster, more confident decision-making for global pharma, biotech, and investment teams.

Based in Spring Lake Heights, New Jersey, OZMOSI is focused on making pharmaceutical intelligence clear, usable, and ready for the future of AI-driven strategy. Learn more at www.ozmosi.com.

About Planview

Planview is the leading end-to-end platform for Strategic Portfolio Management (SPM) and Digital Product Delivery (DPD), powered by advanced AI capabilities that give business and technology leaders the strategic foresight to prioritize investments and initiatives, make plans real within constraints, and pivot with certainty when things change. Our AI-driven connected platform of solutions underpins the business and digital transformations of more than 3,000 customers and 3.1 million users globally. Headquartered in Austin, Texas, Planview has over 1,500 employees worldwide. Learn more at www.planview.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/ozmosi-announces-strategic-partnership-with-planview-to-advance-ai-driven-planning-in-pharmaceutical-rd-302750944.html

SOURCE Ozmosi Company